11.4.2024 14:45:51 CEST | Thor Medical ASA | Additional regulated information required to be disclosed under the laws of a member state
The annual general meeting in Thor Medical ASA (the “Company”) was held today, 11 April 2024. All items on the agenda were approved in accordance with the notice. The minutes are attached hereto and are also available on https://www.thormedical.no/.
Disclosure regulation
This information is required to be disclosed under Section 5-12 of the Securities Trading Act.
Contacts
Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440, brede.ellingseter@thormedical.no
About Thor Medical ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’.
To learn more, visit www.thormedical.no.
Attachments
Download announcement as PDF.pdf
Minutes from ordinary general meeting 2024.pdf
